Literature DB >> 21708850

Starting step III opioids for moderate to severe pain in cancer patients: dose titration: a systematic review.

Pål Klepstad1, Stein Kaasa, Petter C Borchgrevink.   

Abstract

The European Association for Palliative Care recommendation for starting morphine for cancer pain is dose titration with immediate release (IR) oral morphine given every 4 h with additionally doses for breakthrough pain. As part of a EU 6th framework programme to revise the guidelines we review the evidence regarding starting treatment and dose titration of opioids in adult patients with moderate to severe cancer pain. Relevant papers were identified though a systematic search in Medline for papers published until the end of 2009. We identified 15 relevant papers. Thirteen papers were descriptive papers reporting the results from starting treatment with oral morphine (six studies), starting treatment with intravenous morphine (two studies) and starting treatment with transdermal fentanyl (four studies). All treatment strategies resulted in acceptable pain control and were well tolerated. Two randomized controlled trials were identified. One study compared starting opioid treatment with intravenous morphine versus IR oral morphine and one study compared IR oral morphine versus sustained release oral morphine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708850     DOI: 10.1177/0269216310386280

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  8 in total

1.  The association between different opioid doses and the survival of advanced cancer patients receiving palliative care.

Authors:  Anon Sathornviriyapong; Kittiphon Nagaviroj; Thunyarat Anothaisintawee
Journal:  BMC Palliat Care       Date:  2016-11-21       Impact factor: 3.234

2.  Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.

Authors:  Zhiyou Peng; Yanfeng Zhang; Jianguo Guo; Xuejiao Guo; Zhiying Feng
Journal:  Pain Res Manag       Date:  2018-04-04       Impact factor: 3.037

3.  Safety profile of prophylactic rescue dosing of immediate-release oral opioids in cancer patients.

Authors:  Rei Tanaka; Hiroshi Ishikawa; Tetsu Sato; Michihiro Shino; Katsuhiro Omae; Tetsumi Sato; Iwao Osaka
Journal:  J Pharm Health Care Sci       Date:  2018-09-10

Review 4.  Cancer Pain Management: Opioid Analgesics, Part 2.

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2017-09-01

Review 5.  Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue.

Authors:  Lesley A Henson; Matthew Maddocks; Catherine Evans; Martin Davidson; Stephanie Hicks; Irene J Higginson
Journal:  J Clin Oncol       Date:  2020-02-05       Impact factor: 44.544

Review 6.  Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer.

Authors:  Masanori Mori; Takashi Yamaguchi; Yoshinobu Matsuda; Kozue Suzuki; Hiroaki Watanabe; Ryo Matsunuma; Jun Kako; Kengo Imai; Yuko Usui; Yoshihisa Matsumoto; David Hui; David Currow; Tatsuya Morita
Journal:  ESMO Open       Date:  2020-09-30

7.  Patient-controlled subcutaneous analgesia using sufentainil or morphine in home care treatment in patients with stage III-IV cancer: A multi-center randomized controlled clinical trial.

Authors:  Cheng-Fu Wan; Qing-Zhu Meng; Yan-Wei Wang; Liang Qi; Chang-Liang Ai; Xin Sui; Tao Song
Journal:  Cancer Med       Date:  2020-06-04       Impact factor: 4.452

8.  Understanding the Potential for Pharmacy Expertise in Palliative Care: The Value of Stakeholder Engagement in a Theoretically Driven Mapping Process for Research.

Authors:  Joseph Elyan; Sally-Anne Francis; Sarah Yardley
Journal:  Pharmacy (Basel)       Date:  2021-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.